Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center, Randomized, Double-blind, Placebo-controlled, Dose-finding Phase 2b Clinical Trial to Evaluate the Efficacy and Safety of URC102 in Patient With Gout

NCT04804111 is registered in ClinicalTrials.gov with JW Pharmaceutical as lead sponsor.

NCT NCT04804111
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04804111 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center, Randomized, Double-blind, Placebo-controlled, Dose-finding Phase 2b Clinical Trial to Evaluate the Efficacy and Safety of URC102 in Patient With Gout
Lead sponsor
JW Pharmaceutical
Phase
Phase 2
Overall status
Completed
Start date
January 21, 2019
Completion date
November 29, 2020
Enrollment
171 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

gout